Facilitate Project

🌟 Join Us for the II LET's FACILITATE 2024 Webinar! 🌟 We are excited to invite you to an insightful roundtable discussion on "Understanding the Secondary Use of Clinical Trial Data" where we'll explore perspectives from patients, clinicians, industry, and regulators. 🗓 Date: December 11, 2024 ⏰ Time: 2:30 to 4:00 p.m. CET 🔗 Registration: Secure your spot here 👉https://lnkd.in/dAA4FDuV What makes this session unique? A diverse panel of experts and key stakeholders sharing real-world insights on the impact of secondary use of clinical trial data. Don't miss this opportunity if you're engaged in clinical trials or data management—from patients to healthcare professionals, industry leaders, and regulators! We look forward to having you in this dynamic conversation! #IHI #ClinicalTrials #DataManagement #StakeholderEngagement #Webinar

📢 FACILITATE SteerCo Workshop in Paris 🔵After many online meetings, the FACILITATE steering committee team finally gathered in person yesterday and today in Paris! 🎉 We had the opportunity to dive deep into crucial discussions and exchange ideas about the support and competencies required for Work Package 7 on project sustainability as well as the architectural development of the platform in Work Packages 4 & 5, focused on returning data to patients participating in clinical trials. It’s great to be together, brainstorming and working towards our shared goals! 💡 #FACILITATEProject #ClinicalTrials #PatientData #CollaborativeInnovation #Teamwork

Welcome to our podcast series, with which you will immerse into the #FACILITATE world. We will explain you what we mean by returning clinical trial data to participants in a legal and ethical framework within a patient-centric ecosystem. We will familiarise you to the relevance of clinical trial dataset reuse and its impact on future clinical research. 🔵 We will show you what the benefits for the stakeholders are, and which the challenges for an increasingly equitable health and more competitive research in Europe. ❗ Join us on the FACILITATE journey, an example of innovation in the search for a more inclusive, transparent, and patient-focused approach to clinical trials and healthcare. 👇

📢 We continue our appointment with the Facilitate Glossary, today we discover the word: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐇𝐞𝐚𝐥𝐭𝐡 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞 (𝐈𝐇𝐈)- 🔵The Innovative Health Initiative (#IHI) builds on the successes of the Innovative Medicines Initiative (IMI). It is a European public-private partnership dedicated to promoting health research and innovation, but operates in a wider range of areas, with new partners and an updated governance structure. The IMI1 and IMI2 programmes have resulted in almost 200 projects covering a wide range of disease areas and addressing challenges in all areas of medical research and drug development. The IMI projects have yielded impressive results that amply demonstrate the value of a PPP that brings together all stakeholders: universities, large and small companies, patients, regulators, and others. Check it out here: FACILITATE Glossary👉https://lnkd.in/dFPH9PYR #Clinicaltrial #Clinicaltrialdata #Clinicaltrialdatasharing #Reuseofclinicaltrialdata #Clinicaltrialglossary #IHI

𝐖𝐡𝐲 𝐅𝐀𝐂𝐈𝐋𝐈𝐓𝐀𝐓𝐄 𝐚𝐧𝐝 𝐰𝐡𝐲 𝐧𝐨𝐰?   In a rapidly evolving healthcare landscape, the recognition of individual participant clinical data is crucial for addressing unmet medical needs. FACILITATE focuses on: ✔ Enhancing inclusivity, diversity, health equity, and accessibility through adaptable approaches. ✔Advancing clinical data gathering methods and digital health solutions to minimize inconvenience and inefficiency. ✔Promoting interoperability between organizations to bridge healthcare disparities. Join us in this mission to revolutionize clinical trials and data reuse. https://lnkd.in/dw65Tez3 #ClinicalTrials #HealthData #Innovation #FACILITATE

𝐓𝐡𝐞 𝐏𝐨𝐰𝐞𝐫 𝐨𝐟 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥 𝐃𝐚𝐭𝐚  🔵 Each year, approximately 3,000 clinical trials are authorized in Europe, generating billions of data points. Unfortunately, strict privacy laws often silo this data, limiting its reuse and slowing potential advancements in patient care and research. FACILITATE aims to change that by: ✔ Enabling patients and clinicians to access clinical trial data, optimizing decision-making and avoiding redundant procedures. ✔ Reusing clinical research data to benefit future research, making Europe more competitive in clinical trials. Together, universities, clinicians, researchers, patient associations, pharmaceutical companies, and regulators are setting up FACILITATE to make a difference.  Join FACILITATE Pool of stakeholders here 👉  https://lnkd.in/dTKVRTjx #ClinicalResearch #DataReuse #PatientCare #FACILITATE

📣 𝐍𝐞𝐰 𝐕𝐢𝐝𝐞𝐨 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 𝐥𝐚𝐮𝐧𝐜𝐡: 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐩𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐨𝐧 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬!   We're thrilled to share our latest podcast featuring Veronica Popa, Digital Patient Engagement Manager at EURORDIS-Rare Diseases Europe 🔵 In this episode, Veronica discusses: The importance of returning individual clinical trial data to participants. Empowering patients through data ownership and decision-making. The potential of the FACILITATE project in transforming patient-research relationships.   Watch the Podcast Here 👉 https://lnkd.in/dKR--Fiv Join us to explore how clinical trials can better serve patients and improve their lives. #PatientPerspective #ClinicalTrials #RareDiseases #DigitalEngagement

𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐃𝐚𝐭𝐚 𝐎𝐰𝐧𝐞𝐫𝐬𝐡𝐢𝐩  🔵 How returning clinical trial data to participants empowers them and enhances their involvement in research. Data return adds value to patients’ healthcare and management. Participants become part of the decision-making process. Patients’ control over their data and informed consent. Tune in to understand how patient empowerment can redefine clinical trials. Join FACILITATE Pool of stakeholders here 👉 https://lnkd.in/dTKVRTjx #PatientEmpowerment #ClinicalResearch #HealthData #PatientEngagement

📢 We continue our appointment with the Facilitate Glossary, today we discover the word: 𝐄𝐅𝐏𝐈𝐀 🔵The European Federation of Pharmaceutical Industries and Associations (EFPIA - European Federation of Pharmaceutical Industries and Associations) is a Brussels-based trade association founded in 1978 representing the biopharmaceutical industry operating in Europe. The pharmaceutical industry’s key contribution to medical progress is to transform fundamental research into innovative treatments that are widely available and accessible to patients, with the aim of helping people live longer and be healthier. However, huge challenges remain in many disease areas such as Alzheimer’s, multiple sclerosis, many cancers, and orphan diseases.  👉Check it out here: FACILITATE Glossary  https://lnkd.in/dyBJgG7j #Clinicaltrial #Clinicaltrialdata #Clinicaltrialdatasharing #Reuseofclinicaltrialdata #Clinicaltrialglossary #IHI

📢 𝐂𝐚𝐥𝐥𝐢𝐧𝐠 𝐚𝐥𝐥 𝐬𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬! 𝐘𝐨𝐮𝐫 𝐯𝐨𝐢𝐜𝐞 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐈𝐌𝐈 𝐅𝐀𝐂𝐈𝐋𝐈𝐓𝐀𝐓𝐄 𝐏𝐫𝐨𝐣𝐞𝐜𝐭. Join our stakeholders' consultation to shape the future of clinical trial data return. Your expertise is crucial in understanding this vital element. Take part in our few-minute survey to share your views on the process of returning data to clinical trial participants. We've identified key trust dimensions, but we need your input to refine and expand them. Click the link to participate and be heard: 👉https://lnkd.in/d-cWumsE #IMIFACILITATE #ClinicalTrials #PatientCenteredResearch #StakeholderEngagement